scholarly journals N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial

2012 ◽  
Vol 64 (9) ◽  
pp. 2937-2946 ◽  
Author(s):  
Zhi-Wei Lai ◽  
Robert Hanczko ◽  
Eduardo Bonilla ◽  
Tiffany N. Caza ◽  
Brandon Clair ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
T Cells ◽  
Disease Activity ◽  
Lupus Erythematosus ◽  
Controlled Trial ◽  
Mammalian Target Of Rapamycin ◽  
Target Of Rapamycin ◽  
Systemic Lupus ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: A randomized, double-blind, placebo-controlled trial

2002 ◽  
Vol 46 (12) ◽  
pp. 3251-3258 ◽  
Author(s):  
Kenneth C. Kalunian ◽  
John C. Davis ◽  
Joan T. Merrill ◽  
Mark C. Totoritis ◽  
David Wofsy ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
T Cell ◽  
Lupus Erythematosus ◽  
Controlled Trial ◽  
Systemic Lupus ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document